X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
3.240
+0.040 (1.25%)
At close: Oct 23, 2026, 4:00 PM EDT
3.250
+0.010 (0.31%)
After-hours: Oct 23, 2026, 7:30 PM EDT
X4 Pharmaceuticals Employees
X4 Pharmaceuticals had 45 employees as of December 31, 2025. The number of employees decreased by 98 or 68.53% compared to the previous year. That makes X4 Pharmaceuticals the 35,618th largest employer in the world and 4,808th in the United States.
Employees
45
Change (1Y)
-98
Growth (1Y)
-68.53%
Revenue / Employee
$352,156
Profits / Employee
-$2,003,067
Market Cap
321.24M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 45 | -98 | -68.53% |
| Dec 31, 2024 | 143 | 50 | 53.76% |
| Dec 31, 2023 | 93 | 23 | 32.86% |
| Dec 31, 2022 | 70 | -13 | -15.66% |
| Dec 31, 2021 | 83 | 11 | 15.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Artiva Biotherapeutics | 115 |
| Arcturus Therapeutics Holdings | 111 |
| Agenus | 81 |
| Century Therapeutics | 78 |
| Contineum Therapeutics | 51 |
| Surrozen | 44 |
| Inhibikase Therapeutics | 35 |
| Benitec Biopharma | 24 |
XFOR News
- 14 days ago - X4 Pharmaceuticals to Host Virtual Investor Day on Thursday, October 29, 2026, Featuring Key Opinion Leaders - GlobeNewsWire
- 15 days ago - X4 Pharmaceuticals Secures Up to $150 Million Senior Debt Facility with K2 HealthVentures - GlobeNewsWire
- 22 days ago - X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - X4 Pharmaceuticals Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 6 weeks ago - X4 Pharmaceuticals to Participate in a Fireside Chat at the 2026 Wells Fargo Healthcare Conference - GlobeNewsWire
- 6 weeks ago - X4 Pharmaceuticals announces results from Type C Meeting with FDA - TheFly
- 6 weeks ago - X4 Pharmaceuticals Announces Positive Outcome from FDA Type C Meeting - GlobeNewsWire
- 1 month ago - X4 Pharmaceuticals treatment of congenital neutropenia gets orphan designation - TheFly